Pfizer and BioNTech announce the start of BNT162 vaccine trial

Pfizer and BioNTech announced the start of the BNT162 clinical trials on Tuesday, boosting confidence that a potential treatment or vaccine could be around the corner. Yahoo Finance’s Anjalee Khemlani joins The Final Round panel to break down the latest news about the coronavirus.